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Predictors of survival in anuric peritoneal dialysis patients.
Background. Residual glomerular filtration rate (GFR) is a
much more important determinant of survival in peritoneal dial-
ysis patients, than peritoneal solute clearances. However, anuric
peritoneal dialysis patients are solely dependent on peritoneal
solute clearances. The aim of the study was to analyze the ef-
fects of peritoneal small solute clearances and ultrafiltration on
survival in anuric patients, and to establish the minimum levels
of small solute clearances and net ultrafiltration. These objec-
tives were investigated in a prospective cohort study in inci-
dent peritoneal dialysis patients who had become anuric during
follow-up.
Methods. The Netherlands Cooperative Study on the Ad-
equacy of Dialysis (NECOSAD) is a prospective multicenter
cohort study in which new adult dialysis patients are included
and followed during 6 months intervals. Included were 542 peri-
toneal dialysis patients. Of these, 166 developed anuria, 130 of
which could be included in the study.
Results. Two-year patient survival after the outset of anuria
was 67%, technique survival 73%, and the combined 2-year pa-
tient and technique survival was 50%. Risk factors associated
with mortality were age, comorbidity, the duration of peritoneal
dialysis before anuria, and a low serum albumin. Peritoneal
solute clearances were analyzed time-dependently. These pa-
rameters were not associated with survival when analyzed as
continuous variables and also not when the analyses were done
in quintiles, although the time-dependent approach was al-
most significant for Kt/Vurea. On the other hand, when the
results were analyzed dichotomously using predefined cutoff
points, Kt/Vurea <1.5 per week and creatinine clearance <40
L/week/1.73 m2 were associated with an increase in the relative
risk of death. Also peritoneal ultrafiltration was significantly
associated with survival.
Conclusion. The survival of anuric peritoneal dialysis patients
is in line with expectations based on the duration of dialysis. The
risk factors for death are the same as in the dialysis population
as a whole. Besides an association with ultrafiltration, our study
enabled us to define the lower limits of adequate peritoneal
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dialysis, that is Kt/Vurea <1.5 per week and creatinine clearance
<40 L/week/1.73 m2.
In several retrospective and prospective cohort stud-
ies predictors of outcome in patients treated with peri-
toneal dialysis have been investigated [1–17]. Age, the
presence of comorbidity, systolic hypertension, poor nu-
tritional status, and a low serum albumin concentration
were the main factors related to patient survival in these
studies. An effect of the removal of low-molecular-weight
solutes, expressed as Kt/Vurea or weekly creatinine clear-
ance was reported in most series [8–12, 14, 16, 17], but not
in all of them [1, 2, 15]. However, this effect was mainly
dependent on the contribution of residual glomerular fil-
tration rate (GFR) [8, 12, 14, 16–18]. Also, no effect of
peritoneal clearance on patient survival was found in a
randomized controlled trial in Mexico [19]. The survival
of patients without residual renal function is dependent
on peritoneal clearances by definition, as a clearance of
zero will lead to death. The minimum requirement is,
however, unknown. Bhaskaran et al [20] performed a ret-
rospective analysis in anuric peritoneal dialysis patients
in Canada and were unable to find a significant effect of
Kt/Vurea on the relative risk of death. Only when Kt/Vurea
was analyzed dichotomously, that is <1.85 or >1.85 per
week, a nonsignificant (P = 0.1) reduction was found in
the relative risk of death. In contrast, multivariate anal-
ysis of a prospective cohort study in anuric patients in
Hong Kong showed a significant effect of Kt/Vurea on
survival [21]. The majority of these patients were treated
with three 2 L exchanges per day.
Based on the equivocal results of the above studies,
the aim of the present study was to analyze the effects
of peritoneal small solute clearances and ultrafiltration
on survival in anuric patients and to establish the mini-
mum levels of small solute clearances and ultrafiltration.
These objectives were investigated in a prospective co-
hort study in incident peritoneal dialysis patients in The
Netherlands, who had become anuric during follow-up.
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METHODS
Patients
All patients in this study participated in The Nether-
lands Cooperative Study on the Adequacy of Dialysis
(NECOSAD). This is an ongoing prospective multicen-
ter cohort study, in which incident adult (>18 years old)
chronic dialysis patients are included and followed on a
regular basis (see below). Patients with previous renal re-
placement therapy are excluded. Assessments are done
at 0 months, 3 months, 6 months, and every 6 months
thereafter. No recommendations with regard to the dial-
ysis dose are given. The cohort started in January 1997.
At the first of September 2002, 1698 patients had been
included in the cohort and 1489 were on dialysis after 3
months; 542 of these were treated with peritoneal dialy-
sis. For the present analyses, peritoneal dialysis patients
whose 24-hour urine production had dropped to less than
200 mL/day during follow-up were included. The first reg-
ular follow-up assessment where this condition was met
was taken as baseline (onset of anuria) and used in fur-
ther analyses. The NECOSAD study was approved by the
committees of medical ethics of the participating hospi-
tals and informed consent was obtained from all patients
before inclusion.
Data collection
In the NECOSAD study, data are collected on de-
mography, primary renal disease, comorbidity, laboratory
investigations, nutritional status, and therapy character-
istics. Primary renal disease was classified according to
the codes of the European Dialysis and Transplant As-
sociation/European Renal Association (EDTA/ERA).
Comorbidity at the time of development of anuria was
expressed as the Davies risk score [10]. Subjective global
assessment (SGA) was used as measure of the nutritional
status and was performed using the method originally
described by Baker et al [22], modified into a 7-point
scale [11, 23]. Blood laboratory investigations included
hemoglobin, serum albumin, plasma urea, and plasma
creatinine. In a corresponding 24-hour dialysate collec-
tion, urea and creatinine were assessed. The urea dis-
tribution volume (V) used to calculate Kt/Vurea was
obtained by the formulas of Watson, Watson, and Batt
[24]. The dialysate/plasma (D/P) ratio of creatinine was
calculated from the concentrations of creatinine in the
24-hour dialysate and the plasma. Patients were classi-
fied as fast transporters when D/P creatinine was higher
than the mean value plus one standard deviation [25]. The
mean of baseline (start of anuria) and follow-up values
of Kt/Vurea, creatinine clearance, ultrafiltration volume,
hemoglobin, and serum albumin were used for the anal-
yses.
Statistics
All analyses were performed using SAS, version 8 for
Windows software. Follow-up of the patients was cen-
sored at the time of transplantation, at day 60 follow-
ing transfer to hemodialysis, patient withdrawal, or at
September 1, 2002. If a patient died within 60 days af-
ter transfer to hemodialysis, this transfer was disregarded
and his/her death was treated as an event to be attributed
to peritoneal dialysis. Hence, only death occurring dur-
ing or shortly after treatment with peritoneal dialysis was
taken into account (“as-treated” censoring strategy). In
the analysis of technique survival the event was transfer
to hemodialysis and all other observations were censored.
Both death and transfer to hemodialysis were events for
the analysis of the combined patient and technique sur-
vival.
The effects of adequacy on patient, technique, and com-
bined patient and technique survival were assessed in a
multivariate Cox proportional hazards analysis in which
important patient characteristics that are known to in-
fluence outcome were taken into account [26]. These
included age, Davies comorbidity score, SGA, time on
dialysis, serum albumin, and blood hemoglobin concen-
trations. Peritoneal Kt/Vurea, creatinine clearance, and
ultrafiltration were entered as covariates. The analy-
ses were done using the adequacy parameters as time-
dependent covariables. That is, survival is examined in
every 6 months period after the measurement of the ade-
quacy parameters. For each parameter the last observed
value prior to each 6-month interval was used. Kt/Vurea
was included as quintiles in the Cox models for patient
survival, technique survival, and the combined patient
and technique survival. After correction for significant
risk factors in the Cox model, the effect of Kt/Vurea, cre-
atinine clearance, and ultrafiltration on patient and tech-
nique survival were subsequently also analyzed after en-
tering them as continuous variables and dichotomized
at predefined clinically relevant levels. These levels were
a Kt/Vurea of 1.7/week and a creatinine clearance of 45
L/week/1.73 m2, because these are values that are ob-
tained in the majority of continuous ambulatory peri-
toneal dialysis (CAPD) patients. As we wanted to detect
the lower threshold, Kt/Vurea of 1.5 and creatinine clear-
ance of 40 L were also analyzed.
The statistical contribution of a categorized variable
with more than two levels was evaluated by means of
the confidence intervals of the estimated individual pa-
rameters and by means of an overall-test procedure (chi-
square Wald statistic).
RESULTS
A urine production of less than 200 mL/day devel-
oped during follow-up in 166 of the 542 peritoneal dial-
ysis patiends present at 3 months. Of these, 130 could
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Table 1. Demographic variables and comorbidity at time of anuria
(N = 130) [means (SD) or%]
Time on dialysis months 13 (10)
Age at entry years 53 (17)
Gender% male 38
Primary kidney disease%
Diabetes 12
Renovascular 12
Glomerulonephritis 24
Other 52
Davies score% intermediate or high comorbidity 45
Body mass index kg/m2 24.8 (4.0)
Subjective global assessment%
≤5 27
6 28
7 45
be included in the analysis because urine production re-
mained less than 200 mL/day during follow-up and a com-
plete data set on adequacy and nutritional parameters
was available. One hundred and two of these 130 patients
were treated with CAPD, and the remaining 28 with auto-
mated peritoneal dialysis. During follow-up, 32 patients
died. Causes of death were classified as cardiovascular
[12], infectious [3], or various other reasons [17]. Twenty
eight patients received a kidney transplant, 26 patients
were transferred to hemodialysis. Reasons for transfer
to hemodialysis were peritonitis [16], surgical complica-
tions [5], and membrane failure [5]. Demographic and
comorbidity data of the patients at the onset of anuria
are listed in Table 1. Because of the small number of
patients in the subgroup with severe comorbidity, the
subgroups of patients with intermediate and severe co-
morbidity were combined. Biochemical variables and
peritoneal transport characteristics at baseline are listed
in Table 2. Kaplan-Meier survival curves are shown in
Figure 1. Two-year patient survival was 67%, technique
survival 73%, and the combined 2-year patient and tech-
nique survival was 50%.
Multivariate Cox regression analysis revealed several
factors as predictors of patient survival, technique sur-
vival, and the combined patient and technique survival
(Table 3). A higher age, more comorbidity, longer stay
on dialysis before onset of anuria, and low serum albu-
min were all significantly associated with worse patient
survival. When technique survival was studied, we found
a positive relationship between survival and comorbidity.
That is, a high comorbidity was associated with a better
technique survival. Worse nutritional status and fast or
fast average peritoneal membrane transport status had a
negative effect on technique survival.
The effects of peritoneal transport parameters on
patient survival are listed in Table 4. These three param-
eters were each analyzed as continuous variable, as quin-
tiles, and as dichotomous variables using cutoff points
with clinical relevance. Ultrafiltration was significantly
Table 2. Biochemical variables and peritoneal transport
characteristics at time of anuria (N = 130) [means (SD) or%]
Hemoglobin g/dL 11.6 (1.6)
Serum albumin g/dL 3.6. (0.6)
Peritoneal creatinine clearance 48.6 (10.7)
L/week/1.73 m2
Peritoneal Kt/Vurea/week 1.8 (0.3)
Membrane transport status%
Slow/slow average 59
Fast average/fast 41
Ultrafiltration L/day 1.6 (0.6)
associated with survival and creatinine clearance almost
reached statistical significance. Kt/Vurea analyzed as a
continuous variable was not associated with survival. The
lowest quintiles for Kt/Vurea, creatinine clearance, and ul-
trafiltration showed an increased relative risk of death, al-
though statistical significance was not reached. However,
no dose-effect relationship was observed in the other
quintiles. In further dichotomous analysis, it appeared
that Kt/Vurea <1.5 per week and creatinine clearance
<40 L/week/1.73 m2 were associated with a significant
increase in the relative risk of death. The cutoff points
for ultrafiltration did not reach statistical significance. Be-
cause normalizing clearances for a parameter of body size
has been questioned, the analyses in quintiles were also
repeated for Kt and for creatinine clearance not corrected
for body surface area in the time-dependent model. The
overall P value for Kt/Vurea was 0.85 and 0.33 for crea-
tinine clearance. The first was worse than for Kt/Vurea,
while the latter was similar for creatinine clearance/1.73
m2 body surface area. Also including body mass index in
the multivariate models had no significant effects (data
not shown).
Similar analyses as for mortality were done for tech-
nique survival, and are shown in Table 5. A tendency was
present (P < 0.1) for an association between creatinine
clearance and an increased risk of technique failure, both
in the analysis in quintiles and in the one using creati-
nine clearance as a continuous variable. Analysis using
the cutoff points showed no association. Moreover, no
associations were found for Kt/Vurea and ultrafiltration
with technique survival.
DISCUSSION
The effects of the dialysis dose on the survival of dialysis
patients is best studied in those who have no or negligi-
ble residual urine production, because these patients are
totally dependent on dialysis for the removal of uremic
waste products, and excess of fluid. It has been shown in a
randomized controlled trial in Mexico that increasing the
peritoneal creatinine clearance to 60 Lweek/1.73 m2 had
no effect on the survival of anuric patients [19]. This cor-
responds with an increase of Kt/Vurea from an average of
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Fig. 1. Kaplan-Meier curves for the proba-
bility of patient survival (bold line), tech-
nique survival (normal line) and the com-
bined patient and technique survival (dashed
line). In the analyses for patient survival,
the event is death, whereas transplantation,
transfer to hemodialysis, and lost to follow-
up are censored observations. In the analy-
ses of technique survival the event is trans-
fer to hemodialysis, while all other observa-
tions are censored. Both death and transfer
to hemodialysis are events in the combined
patient and technique survival curves.
Table 3. Multivariate Cox regression analysis of patient survival, technique survival, and combined patient and tchnique survival
Combined patient and
Patient survival Technique survival technique survival
(N = 130/32 events) (N = 130/26 events) (N = 130/58 events)
RR 95% CI P value RR 95% CI P value RR 95% CI P value
Age at entry years 1.08 1.04–1.12 <0.001 NS 1.03 1.02–1.05 0.001
Davies score NS
Low 1 1
Intermediate/high 3.83 1.19–12.4 0.02 0.40 0.17–0.93 0.03
Subjective global assessment
≤5 1.88 0.73–4.85 0.19 5.30 1.95–14.4 0.001 3.32 1.75–6.27 <0.001
6 0.49 0.15–1.60 0.23 2.14 0.75–6.06 0.15 1.15 0.55–2.40 0.7
7 1 1 1
P overall 0.08 P overall 0.004 P overall <0.001
Time on dialysis
<11/2 years 0.36 0.15–0.89 0.03 NS 0.46 0.25–0.85 0.01
>11/2 years 1 1
Albumin g/dL 0.43 0.20–0.91 0.03 NS NS
Hemoglobin g/dL 0.70 0.48–1.02 0.07 NS NS
Membrane transport status NS NS
Slow/slow average 0.41 0.17–0.98 0.05
Fast average/fast 1
Table 4. Influence of clearance parameters on patient survival corrected for age, Davies score, subjective global assessment, time on dialysis,
serum albumin, and hemoglobin concentration
Kt/Vurea/week Creatinine clearance L/week/1.73m2 Ultrafiltration L/day
RR 95% CI P value RR 95% CI P value RR 95% CI P value
Continuous 0.43 0.11–1.66 0.22 0.96 0.92–1.00 0.08 0.48 0.23–0.97 0.04
Quintiles <1.49 3.17 0.74–13.43 0.12 <41.3 2.71 0.79–9.25 0.11 <1.15 3.41 0.70–16.57 0.13
1.49–1.67 1.11 0.25–4.87 0.89 41.3–46.5 0.79 0.20–3.08 0.74 1.15–1.50 1.70 0.31–9.08 0.53
1.67–1.84 0.37 0.07–1.92 0.24 46.5–50.0 1.41 0.42–4.65 0.57 1.50–1.85 3.09 0.56–17.03 0.19
1.84–2.14 1.31 0.34–5.03 0.69 50.0–56.6 0.99 0.29–3.39 0.99 1.85–2.20 2.29 0.30–17.28 0.42
≥2.14 1 ≥56.6 1 ≥2.20 1
P overall 0.06 P overall 0.36 P overall 0.47
Cutoff points <1.7 (50) 1.47 (50) 0.70–3.12 0.31 <45 (29) 1.37 0.58–3.20 0.46 <1.25 (30) 2.29 0.82–6.38 0.11
≥1.7 (80) 1.00 (80) ≥45 (101) 1.00 ≥1.25 (94) 1.00
<1.5 (15) 3.28 (15) 1.25–8.60 0.02 <40 (13) 3.26 1.24–8.55 0.02 <1.0 (14) 2.20 0.78–6.15 0.13
≥1.5 (115) 1 (115) ≥40 (117) 1 ≥1.0 (110) 1
The figures in parentheses give the number of patients per group.
1.7 per week to 2.0. It is evident, however, that mortality
will be increased below a certain dose. The establishment
of a lower adequacy limit can not be done in a random-
ized controlled trial because of obvious ethical reasons.
Therefore, carefully designed prospective controlled co-
hort studies with a wide variation in the prescribed dial-
ysis dose are required. The NECOSAD cohort is such
a study because measurements of renal function and
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Table 5. Influence of clearance parameters on technique survival corrected for age, Davies score, subjective global assessment, time on dialysis,
serum albumin, and hemoglobin concentration
Kt/Vurea/week Creatinine clearance L/week/1.73m2 Ultrafiltration L/day
RR 95% CI P value RR 95% CI P value RR 95% CI P value
Continuous 1.51 0.43-5.33 0.52 1.02 0.99-1.04 0.12 1.13 0.59–2.14 0.70
Quintiles <1.49 NA <41.3 0.85 0.15–4.72 0.86 <1.15 0.61 0.17–2.19 0.45
1.49–1.67 1.21 0.32–4.08 0.76 41.3–46.5 0.38 0.07–1.85 0.23 1.15–1.50 0.87 0.25–2.98 0.83
1.67–1.84 1.08 0.31–3.80 0.89 46.5–50.0 0.74 0.20–2.63 0.64 1.50–1.85 1.38 0.46–4.14 0.56
1.84–2.14 0.80 0.23–2.79 0.73 50.0–56.6 2.50 0.91–6.85 0.07 1.85–2.20 0.37 0.07–1.92 0.24
≥2.14 1.00 ≥56.6 1.00 ≥2.20 1.00
P overall 0.96 P overall 0.08 P overall 0.48
Cutoff points <1.7 1.22 0.55–2.70 0.62 <45 0.57 0.18–1.76 0.33 <1.25 0.45 0.15–1.36 0.16
≥1.7 1.00 . ≥45 1.00 ≥1.25 1.00
<1.5 NA <40 1.03 0.21-4.93 0.96 <1.0 0.87 0.28–2.68 0.81
≥1.5 ≥40 1.00 ≥1.0 1.00
NA is not analyzed because of a small number of events.
dialysis dose are performed at 6-month intervals and the
patients are well characterized with regard to comorbid-
ity and nutritional status.
The present analysis in the NECOSAD cohort of pa-
tients who had become anuric during follow-up showed
that patient and technique survival on peritoneal dial-
ysis, mainly CAPD, was similar to the values reported
by the EDTA/ERA for incident hemodialysis and peri-
toneal dialysis patients, the majority of them having resid-
ual renal function at the start of dialysis [27]. Patient sur-
vival in the anuric peritoneal dialysis patients was lower
than that of all peritoneal dialysis patients included in
NECOSAD [26]: 2-year survival 67% versus 84%. How-
ever, this can be explained by the duration of peritoneal
dialysis prior to the outset of anuria. In the present study,
duration of peritoneal dialysis of less than 1 12 years prior
to the onset of anuria was associated with a 64% reduc-
tion in the risk of death compared to a duration exceeding
1 12 years. This is in accordance with our finding in the
whole NECOSAD peritoneal dialysis population [26].
The recently published European APD Outcome Study
(EAPOS) in anuric ambulatory peritoneal dialysis
(APD) patients showed similar survival results, espe-
cially the combined 2-year patient and technique sur-
vival, which was almost identical [28]. These survival
data do not support the fear that anuric peritoneal dial-
ysis patients can often not be treated adequately with
CAPD [29]. The values found for technique survival in
the present study also make it unlikely that some, for
instance, patients with a high body mass index, have
been transferred to hemodialysis shortly after becom-
ing anuric. Peritonitis, surgical complications, and “mem-
brane failure,” including underdialysis and ultrafiltra-
tion failure, were the reported causes for transfer to
hemodialysis. A surprising finding was the association
between the presence of intermediate/high comorbidity
and a high technique survival. The explanation is specu-
lative, but one could assume that patients with a poor car-
diac condition were considered to be unfit for transfer to
hemodialysis.
The well-known risk factors associated with decreased
patient survival, such as age, comorbidity, nutritional sta-
tus, and serum albumin, as reported in many studies, in-
cluding the EAPOS [28], were also found in the anuric
patients of the present study. In contrast to some other
studies, peritoneal transport status was not associated
with patient survival [30] or with the combined patient
and technique survival [31]. However, a significant asso-
ciation with technique survival was present. A fast peri-
toneal transport status can lead to ultrafiltration failure
and to a low Kt/Vurea [30]. Our data, therefore, suggest
that the threshold to transfer these patients to hemodial-
ysis was low.
None of the peritoneal solute transport parameters
was significantly associated with patient survival when
analyzed as continuous variables. However, normalized
peritoneal creatinine clearance showed a tendency for an
association between higher clearances and survival. The
failure to reach statistical significance might have been
due to a type II error, caused by the relatively low num-
ber of patients.
The analysis in quintiles showed an almost significant
excess mortality for the group with the lowest Kt/Vurea. It
can be seen from the extent of the clearance values that a
wide range was present. This may explain the difference
between our study and that of Szeto et al [21]. In the lat-
ter study from Hong Kong, the dialysis dose per patient
was less flexible than in The Netherlands because of fi-
nancial constrains. Also, the overall dose was lower and
the patients transferred to hemodialysis were apparently
not censored in the analysis of patient survival.
The use of various cutoff points enabled us to define
the lowest adequacy limits below which mortality was
significantly increased. These limits, Kt/Vurea <1.5/week,
creatinine clearance <40 L/week/1.73 m2, were markedly
lower than generally assumed. This obviously does not
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mean that they can be used directly in guidelines on the
dialysis dose because a safety margin should always be
present. However, these adequacy threshold levels sug-
gest that a Kt/Vurea of 1.7/week and a creatinine clearance
of at least 45 L/week are reasonable targets. It is also in
line with the results of the ADEMEX Study showing that
a further increase of these solute transport levels does not
lead to better patient survival [19].
Anuric peritoneal dialysis patients are at risk for the de-
velopment of overhydration, especially when they have
ultrafiltration failure. Therefore peritoneal ultrafiltration
was included as an adequacy parameter. A significant as-
sociation was found with mortality in the time-dependent
analysis. These findings are in line with those of the EA-
POS where net ultrafiltration below 750 mL/24 hours pre-
dicted a higher mortality when compared to a volume
above this value [28].
CONCLUSION
It can be concluded that anuric peritoneal dialysis pa-
tients have an acceptable patient and technique survival.
The risk factors for death are the same as in the dialy-
sis population as a whole. A peritoneal Kt/Vurea below
1.5/week, a creatinine clearance below 40 L/week/1.73
m2, and a lower peritoneal ultrafiltration volume were all
associated with an increased risk of death.
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